Dr Teresa Deisher on Fetal Cells in Vaccines

Theresa Deisher, Ph.D. (President, Sound Choice Pharmaceutical Institute, CEO and Managing Member, AVM Biotechnology). Dr. Deisher, an expert in the field of adult stem cell therapies and regenerative medicine, brings 18 years of experience in scientific and corporate leadership positions involving research, discovery, production and commercialization of human therapeutics. Dr. Deisher’s penchant for ground breaking scientific discovery and her distinguished scientific research has resulted in 23 patents issued in her name. She has published numerous scientific manuscripts and is a frequent invited lecturer and guest speaker in the area of stem cell technology and regenerative medicine. Throughout her career, Dr. Deisher has been recruited by some of the country’s top biotechnology companies, including Genentech, Repligen, Zymo Genetics, Immunex and Amgen. She has managed and mentored undergraduate honors students, post-doctoral fellows, scientific executives and over 20 research assistants/scientists at all levels of responsibility Dr. Deisher graduated with honors and distinction from Stanford University, and obtained her Ph.D. in Molecular and Cellular Physiology from the Department of Molecular and Cellular Physiology, Stanford University.